|
1.
|
|
9 p, 627.4 KB |
Effects of alirocumab on types of myocardial infarction : Insights from the ODYSSEY OUTCOMES trial
/
White, Harvey D. (Auckland City Hospital) ;
Gabriel Steg, P. (Royal Brompton Hospital (Londres)) ;
Szarek, Michael (SUNY Downstate Medical Center School of Public Health) ;
Bhatt, Deepak L (Harvard Medical School) ;
Bittner, Vera A. (University of Alabama at Birmingham) ;
Diaz, Rafael (Instituto Cardiovascular de Rosario) ;
Edelberg, Jay M. (Sanofi) ;
Erglis, Andrejs (University of Latvia) ;
Goodman, Shaun G. (University of Toronto) ;
Hanotin, Corinne (Sanofi) ;
Harrington, Robert A. (Department of Medicine) ;
Wouter Jukema, J. (Leiden University Medical Center) ;
Lopes, Renato D. (Duke Clinical Research Institute) ;
Mahaffey, Kenneth W. (Stanford University School of Medicine) ;
Moryusef, Angele (Sanofi) ;
Pordy, Robert (Regeneron Pharmaceuticals) ;
Roe, Matthew T. (Duke Clinical Research Institute) ;
Sritara, Piyamitr (Mahidol University) ;
Tricoci, Pierluigi (CSL Behring) ;
Zeiher, Andreas Michael (Goethe University) ;
Schwartz, Gregory G. (University of Colorado School of Medicine) ;
Cequier Fillat, Angel R. (hospital Universitari de Bellvitge) ;
Garcia-Dorado, David (Hospital Universitari Vall d'Hebron) ;
Matas Pericas, Laia (Institut d'Investigació Biomèdica Sant Pau) ;
Bruguera Cortada, Jordi (Hospital del Mar (Barcelona, Catalunya)) ;
Gusi Tragant, Gabriel (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ;
Coca Payeras, Antoni (Hospital Clínic i Provincial de Barcelona) ;
Universitat Autònoma de Barcelona
The third Universal Definition of Myocardial Infarction (MI) Task Force classified MIs into five types: Type 1, spontaneous; Type 2, related to oxygen supply/demand imbalance; Type 3, fatal without ascertainment of cardiac biomarkers; Type 4, related to percutaneous coronary intervention; and Type 5, related to coronary artery bypass surgery. [...]
2019 -  10.1093/eurheartj/ehz299
European heart journal, Vol. 40 Núm. 33 (january 2019) , p. 2801-2809
|
|
|
2.
|
|
10 p, 396.0 KB |
Alirocumab Reduces Total Nonfatal Cardiovascular and Fatal Events : The ODYSSEY OUTCOMES Trial
/
Szarek, Michael (State University of New York) ;
White, Harvey D. (University of Auckland and Green Lane Cardiovascular Services Auckland City Hospital) ;
Schwartz, Gregory G. (Division of Cardiology. University of Colorado School of Medicine) ;
Alings, Marco (Amphia Ziekenhuis Molengracht) ;
Bhatt, Deepak L (Brigham and Women's Hospital Heart & Vascular Center and Harvard Medical School) ;
Bittner, Vera A. (University of Alabama at Birmingham) ;
Chiang, Chern-En (Taipei Veterans General Hospital and National Yang-Ming University) ;
Diaz, Rafael (Instituto Cardiovascular de Rosario) ;
Edelberg, Jay M. (Sanofi) ;
Goodman, Shaun G. (University of Toronto) ;
Hanotin, Corinne (Sanofi) ;
Harrington, R.A. (Stanford University) ;
Jukema, J.Wouter (Leiden University Medical Center) ;
Kimura, Takeshi (Kyoto University Graduate School of Medicine) ;
Kiss, Robert Gabor (Magyar Honvédség Egészségügyi Központ) ;
Lecorps, Guillaume (Sanofi) ;
Mahaffey, Kenneth W. (Stanford University) ;
Moryusef, Angèle (Sanofi) ;
Pordy, Robert (Regeneron Pharmaceuticals Inc.) ;
Roe, Matthew T. (Duke University Medical Center) ;
Tricoci, Pierluigi (Duke University Medical Center) ;
Xavier, Denis (St. John's Medical College and Research Institute) ;
Zeiher, Andreas Michael (Goethe University) ;
Steg, Ph Gabriel (Royal Brompton Hospital (Londres)) ;
Cequier Fillat, Angel R. (Hospital Universitari de Bellvitge) ;
Garcia-Dorado, David (Hospital Universitari Vall d'Hebron) ;
Matas Pericas, Laia (Institut d'Investigació Biomèdica Sant Pau) ;
Bruguera Cortada, Jordi (Hospital del Mar (Barcelona, Catalunya)) ;
Gusi Tragant, Gabriel (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ;
Coca Payeras, Antonio (Hospital Clínic i Provincial de Barcelona) ;
Universitat Autònoma de Barcelona
The ODYSSEY OUTCOMES (Evaluation of Cardiovascular Outcomes After an Acute Coronary Syndrome During Treatment With Alirocumab) trial compared alirocumab with placebo, added to high-intensity or maximum-tolerated statin treatment, after acute coronary syndrome (ACS) in 18,924 patients. [...]
2019 - 10.1016/j.jacc.2018.10.039
Journal of the American College of Cardiology, Vol. 73 Núm. 4 (may 2019) , p. 387-396
|
|
|
3.
|
|
10 p, 324.1 KB |
Alirocumab in Patients With Polyvascular Disease and Recent Acute Coronary Syndrome : ODYSSEY OUTCOMES Trial
/
Jukema, J.Wouter (Leiden University Medical Center) ;
Szarek, Michael (State University of New York) ;
Zijlstra, Laurien E. (Leiden University Medical Center) ;
de Silva, H.Asita (University of Kelaniya) ;
Bhatt, Deepak L (Brigham and Women's Hospital Heart & Vascular Center and Harvard Medical School) ;
Bittner, Vera A. (University of Alabama at Birmingham) ;
Diaz, Rafael (Cardiovascular Institute of Rosario) ;
Edelberg, Jay M. (Sanofi) ;
Goodman, Shaun G. (St. Michael's Hospital. University of Toronto) ;
Hanotin, Corinne (Sanofi) ;
Harrington, Robert A. (Stanford University) ;
Karpov, Yuri (Russian Cardiological Scientific-Productive Complex) ;
Moryusef, Angèle (Sanofi) ;
Pordy, Robert (Regeneron Pharmaceuticals. Inc.) ;
Prieto, Juan C. (University of Chile Clinical Hospital) ;
Roe, Matthew T. (Duke University School of Medicine) ;
White, Harvey D. (Green Lane Cardiovascular Services Auckland City Hospital) ;
Zeiher, Andreas Michael (Goethe University) ;
Schwartz, Gregory G. (University of Colorado School of Medicine) ;
Steg, P.Gabriel (Royal Brompton Hospital (Londres)) ;
Cequier, Ángel (Hospital Universitari de Bellvitge) ;
García-Dorado, David (Hospital Universitari Vall d'Hebron) ;
Mata Pericas, Laia (Institut d'Investigació Biomèdica Sant Pau) ;
Bruguera Cortada, Jordi (Hospital del Mar (Barcelona, Catalunya)) ;
Gusi Tragant, Gabriel (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ;
Coca Payeras, Antonio (Hospital Clínic i Provincial de Barcelona) ;
Universitat Autònoma de Barcelona
Patients with acute coronary syndrome (ACS) and concomitant noncoronary atherosclerosis have a high risk of major adverse cardiovascular events (MACEs) and death. The impact of lipid lowering by proprotein convertase subtilisin-kexin type 9 inhibition in such patients is undetermined. [...]
2019 - 10.1016/j.jacc.2019.03.013
Journal of the American College of Cardiology, Vol. 74 Núm. 9 (march 2019) , p. 1167-1176
|
|
|
4.
|
|
12 p, 648.4 KB |
Effect of Alirocumab on Lipoprotein(a) and Cardiovascular Risk After Acute Coronary Syndrome
/
Bittner, Vera A. (University of Alabama at Birmingham) ;
Szarek, Michael (State University of New York) ;
Aylward, Philip (South Australian Health and Medical Research Institute) ;
Bhatt, Deepak L. (Brigham and Women's Hospital Heart & Vascular Center and Harvard Medical School) ;
Díaz, Rafaël J. (Instituto Cardiovascular de Rosario) ;
Edelberg, Jay M. (Sanofi) ;
Fras, Zlatko (Univerza V Ljubljani) ;
Goodman, Shaun G. (University of Toronto) ;
Halvorsen, Sigrun (University of Oslo) ;
Hanotin, Corinne (Sanofi) ;
Harrington, Robert A. (Stanford University) ;
Jukema, J. Wouter (Leiden University Medical Center) ;
Loizeau, Virginie (Sanofi) ;
Moriarty, Patrick Maurice (University of Kansas Medical Center) ;
Moryusef, Angèle (Sanofi) ;
Pordy, Robert (Regeneron Pharmaceuticals Inc.) ;
Roe, Matthew T. (Duke University School of Medicine) ;
Sinnaeve, Peter (University of Leuven) ;
Tsimikas, Sotirios (University of California San Diego) ;
Vogel, Robert A. (University of Colorado School of Medicine) ;
White, Harvey D. (Green Lane Cardiovascular Services Auckland City Hospital) ;
Zahger, Doron (Soroka University Medical Center) ;
Zeiher, Andreas Michael (Goethe University) ;
Steg, Philippe Gabriel (Royal Brompton Hospital (Londres)) ;
Schwartz, Gregory G. (University of Colorado School of Medicine) ;
Matas Pericas, Laia (Institut d'Investigació Biomèdica Sant Pau) ;
Gusi Tragant, Gabriel (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ;
Coca Payeras, Antonio (Hospital Clínic i Provincial de Barcelona) ;
Cequier, Ángel (Hospital Universitari de Bellvitge) ;
García-Dorado, David (Hospital Universitari Vall d'Hebron) ;
Bruguera Cortada, Jordi (Hospital del Mar (Barcelona, Catalunya)) ;
Universitat Autònoma de Barcelona
Lipoprotein(a) concentration is associated with cardiovascular events. Alirocumab, a proprotein convertase subtilisin/kexin type 9 inhibitor, lowers lipoprotein(a) and low-density lipoprotein cholesterol (LDL-C). [...]
2020 - 10.1016/j.jacc.2019.10.057
Journal of the American College of Cardiology, Vol. 75 Núm. 2 (21 2020) , p. 133-144
|
|
|
5.
|
|
21 p, 1.7 MB |
Persistent pulmonary hypertension in corrected valvular heart disease : Hemodynamic insights and long-term survival
/
Bermejo, Javier (Hospital General Universitario Gregorio Marañón. Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM)) ;
González-Mansilla, Ana (Hospital General Universitario Gregorio Marañón. Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM)) ;
Mombiela, Teresa (Hospital General Universitario Gregorio Marañón. Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM)) ;
Fernández, Ana I. (Hospital General Universitario Gregorio Marañón. Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM)) ;
Martínez-Legazpi, Pablo (Hospital General Universitario Gregorio Marañón. Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM)) ;
Yotti, Raquel (Instituto de Salud Carlos III) ;
García-Orta, Rocío (Hospital Universitario Virgen de las Nieves (Granada)) ;
Sánchez-Fernández, Pedro L. (Hospital Clínico Universitario (Salamanca)) ;
Castaño-Ruiz, Mario (Hospital Universitario de León) ;
Segovia-Cubero, Javier (Hospital Universitario Puerta de Hierro Majadahonda (Madrid)) ;
Escribano-Subias, Pilar (Hospital Universitario 12 de Octubre (Madrid)) ;
San Román, J.Alberto (Hospital Clínico Universitario de Valladolid) ;
Borràs Pino, Xavier (Institut d'Investigació Biomèdica Sant Pau) ;
Alonso-Gómez, Ángel María (Arabako Unibertsitate Ospitalea (Vitoria, País Basc)) ;
Botas, Javier (Hospital Universitario Fundación Alcorcón) ;
Crespo-Leiro, Maria Generosa (Complejo Hospitalario Universitario de A Coruña) ;
Velasco, Sonia (Hospital de Galdakao (Usansolo, Biscaia)) ;
Bayés-Genís, Antoni (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
López, Amador (Hospital Universitario Reina Sofía (Còrdova, Espanya)) ;
Muñoz-Aguilera, Roberto (Hospital Universitario Infanta Leonor) ;
Jiménez-Navarro, Manuel (Hospital Universitario Virgen de la Victoria (Màlaga, Andalusia)) ;
González-Juanatey, José R. (Hospital Clínico Universitario (Santiago de Compostela, Galícia)) ;
Evangelista, Arturo (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Elízaga, Jaime (Hospital General Universitario Gregorio Marañón. Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM)) ;
Martín-Moreiras, Javier (Hospital Clínico Universitario (Salamanca)) ;
González-Santos, José M. (Hospital Clínico Universitario (Salamanca)) ;
Moreno-Escobar, Eduardo (Hospital Universitario San Cecilio (Granada)) ;
Fernández Avilés, F. (Hospital General Universitario Gregorio Marañón. Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM)) ;
García-Robles, José A. (Hospital General Universitario Gregorio Marañón. Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM)) ;
Pérez-David, Esther (Hospital General Universitario Gregorio Marañón. Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM)) ;
Pérez Del Villar, Candelas (Hospital General Universitario Gregorio Marañón. Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM)) ;
Sanz, Ricardo (Hospital General Universitario Gregorio Marañón. Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM)) ;
Gutierrez-Ibanes, Enrique (Hospital General Universitario Gregorio Marañón. Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM)) ;
Vázquez, María E. (Hospital General Universitario Gregorio Marañón. Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM)) ;
Mur, Ana (Hospital General Universitario Gregorio Marañón. Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM)) ;
Benito, Yolanda (Hospital General Universitario Gregorio Marañón. Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM)) ;
Barrio, Alicia (Hospital General Universitario Gregorio Marañón. Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM)) ;
Vázquez, Alexandra (Hospital General Universitario Gregorio Marañón. Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM)) ;
Uribe, Inés (Hospital Universitario Virgen de las Nieves (Granada)) ;
González, Mercedes (Hospital Universitario Virgen de las Nieves (Granada)) ;
Arribas Jiménez, Antonio (Hospital Clínico Universitario (Salamanca)) ;
Clemente Lorenzo, M. Milagros (Hospital Clínico Universitario (Salamanca)) ;
Nieto, Alejandro Diego (Hospital Clínico Universitario (Salamanca)) ;
Pérez De Prado, Armando (Hospital Universitario de León) ;
Alonso Rodríguez, David (Hospital Universitario de León) ;
Gómez-Bueno, Manuel (Hospital Universitario Puerta de Hierro Majadahonda (Madrid)) ;
Sayago Silva, Inés (Hospital Universitario Puerta de Hierro Majadahonda (Madrid)) ;
Cavero, Miguel Ángel (Hospital Universitario Puerta de Hierro Majadahonda (Madrid)) ;
Domínguez, Laura (Hospital Universitario 12 de Octubre (Madrid)) ;
Tello De Meneses, Rocío (Hospital Universitario 12 de Octubre (Madrid)) ;
Ruíz Cano, María José (Hospital Universitario 12 de Octubre (Madrid)) ;
Jiménez López-Guarch, Carmen (Hospital Universitario 12 de Octubre (Madrid)) ;
Mota, Pedro (Hospital Clínico Universitario de Valladolid) ;
Amorós Galitó, Carmen (CIBERCV) ;
Belló Mora, M. Concepción (Arabako Unibertsitate Ospitalea (Vitoria, País Basc)) ;
Mesa Rubio, Dolores (Arabako Unibertsitate Ospitalea (Vitoria, País Basc)) ;
Campuzano, Raquel (Complejo Universitario Fundación Alcorcón) ;
Marzoa, Raquel (Complejo Hospitalario Universitario de A Coruña) ;
Cuenca, José (Complejo Hospitalario Universitario de A Coruña) ;
Muñoz, Roberto (Hospital Universitario Infanta Leonor) ;
Suberviola, Verónica (Hospital Universitario Infanta Leonor) ;
Beltrán Herrera, Cristina (Hospital Universitario Infanta Leonor) ;
Mora, Laura (Hospital Universitario Infanta Leonor) ;
Sarrión, M. Mar (Hospital Universitario Infanta Leonor) ;
Vaqueriza, David (Hospital Universitario Infanta Leonor) ;
Ferrer, Elena (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Cid-Álvarez, Belén (Hospital Clínico Universitario (Santiago de Compostela, Galícia)) ;
Martínez Monzonís, Amparo (Hospital Clínico Universitario (Santiago de Compostela, Galícia)) ;
Arizón, J. M. (Hospital Universitario Reina Sofía (Còrdova, Espanya)) ;
Santisteban, Marta (Hospital Universitario Reina Sofía (Còrdova, Espanya)) ;
García-Dorado, David (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
De Teresa, Eduardo (Hospital Universitario Virgen de la Victoria (Màlaga, Andalusia)) ;
Carrasco-Chinchilla, Fernando (Hospital Universitario Virgen de la Victoria (Màlaga, Andalusia)) ;
Alonso, Joaquín (Hospital Universitario de Getafe (Madrid))
BACKGROUND: The determinants and consequences of pulmonary hypertension after successfully corrected valvular heart disease remain poorly understood. We aim to clarify the hemodynamic bases and risk factors for mortality in patients with this condition. [...]
2021 - 10.1161/JAHA.120.019949
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol. 10 Núm. 2 (2021) , p. 1-21
|
|
|
6.
|
|
12 p, 612.6 KB |
Optimal opportunistic screening of atrial fibrillation using pulse palpation in cardiology outpatient clinics : Who and how
/
Bañeras, Jordi (Hospital Universitari Vall d'Hebron) ;
Pariggiano, Ivana (University of Campania "Luigi Vanvitelli") ;
Ródenas-Alesina, Eduard (Hospital Universitari Vall d'Hebron) ;
Oristrell, Gerard (Hospital Universitari Vall d'Hebron) ;
Escalona, Roxana (Hospital Universitari Vall d'Hebron) ;
Miranda, Berta (Hospital Universitari Vall d'Hebron) ;
Rello, Pau (Hospital Universitari Vall d'Hebron) ;
Soriano-Colomé, Toni (Hospital Universitari Vall d'Hebron) ;
Gordon, Blanca (Hospital Universitari Vall d'Hebron) ;
Belahnech, Yassin (Hospital Universitari Vall d'Hebron) ;
Calabrò, Paolo (University of Campania "Luigi Vanvitelli") ;
García-Dorado, David (CIBER CV, ISC-III, Madrid, Spain) ;
Ferreira-Gonzalez, Ignacio (Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública) ;
Radua, Joaquim (Karolinska Institutet (Estocolm, Suècia)) ;
Universitat Autònoma de Barcelona
Atrial fibrillation (AF) remain a prevalent undiagnosed condition frequently encountered in primary care. We aimed to find the parameters that optimize the diagnostic accuracy of pulse palpation to detect AF. [...]
2022 - 10.1371/journal.pone.0266955
PloS one, Vol. 17 (april 2022)
|
|
|
7.
|
|
6 p, 400.3 KB |
MRI Discriminates Thrombus Composition and ST Resolution after Percutaneous Coronary Intervention in Patients with ST-Elevation Myocardial Infarction
/
Barba, Ignasi (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
García del Blanco, Bruno (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Abdul-Jawad Altisent, Omar (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Barrabés, José A.. (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Martí Balaguer, Gerard (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Domingo Ribas, Enric (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Angel, Joan (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
García-Dorado, David (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Universitat Autònoma de Barcelona
Histological composition of material obtained by thrombus aspiration during percutaneous coronary intervention (PCI) in patients with ST-segment elevation acute myocardial infarction (STEMI) is highly variable. [...]
2011 - 10.1371/journal.pone.0018459
PloS one, Vol. 6 (april 2011)
|
|
|
8.
|
|
15 p, 2.0 MB |
Effects of the Selective Stretch-Activated Channel Blocker GsMtx4 on Stretch-Induced Changes in Refractoriness in Isolated Rat Hearts and on Ventricular Premature Beats and Arrhythmias after Coronary Occlusion in Swine
/
Barrabés, José A.. (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Inserte, Javier (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Agulló, Luis (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Rodríguez-Sinovas, Antonio (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Alburquerque-Béjar, Juan Jos. (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
García-Dorado, David (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Universitat Autònoma de Barcelona
Mechanical factors may contribute to ischemic ventricular arrhythmias. GsMtx4 peptide, a selective stretch-activated channel blocker, inhibits stretch-induced atrial arrhythmias. We aimed to assess whether GsMtx4 protects against ventricular ectopy and arrhythmias following coronary occlusion in swine. [...]
2015 - 10.1371/journal.pone.0125753
PloS one, Vol. 10 (may 2015)
|
|
|
9.
|
|
|
10.
|
|
24 p, 1.4 MB |
Ischaemic conditioning and targeting reperfusion injury : a 30 year voyage of discovery
/
Hausenloy, Derek J. (National Heart Research Institute Singapore) ;
Barrabés, José A.. (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Bøtker, Hans Erik (Aarhus University Hospital (Aarhus, Dinamarca)) ;
Davidson, Sean M. (University College London) ;
Di Lisa, Fabio (University of Padova, Italy) ;
Downey, James (University of South Alabama, Mobile) ;
Engstrom, Thomas (Copenhagen University Hospital) ;
Ferdinandy, Péter (Pharmahungary Group, Szeged, Hungary) ;
Carbrera-Fuentes, Hector A. (Kazan Federal University, Russian Federation) ;
Heusch, Gerd (University of Essen Medical School, Germany) ;
Ibanez, Borja (Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz) ;
Iliodromitis, Efstathios K. (National and Kapodistrian University of Athens, Greece) ;
Inserte, Javier (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Jennings, Robert (Duke University, Durham, NC USA) ;
Kalia, Neena (University of Birmingham, UK) ;
Kharbanda, Rajesh (Oxford University Hospitals, UK) ;
Lecour, Sandrine (University of Cape Town, South Africa) ;
Marber, Michael (St. Thomas' Hospital, London, UK) ;
Miura, Tetsuji (Sapporo Medical University School of Medicine, Japan) ;
Ovize, Michel (Université Claude Bernard, Lyon 1, France) ;
Perez-Pinzon, Miguel A. (University of Miami Miller School of Medicine, USA) ;
Piper, Hans Michael (Carl von Ossietzky Universität Oldenburg) ;
Przyklenk, Karin (Wayne State University, Detroit, USA) ;
Schmidt, Michael Rahbek (Duke-National University of Singapore) ;
Redington, Andrew (Cincinnati Children's Hospital Medical Center) ;
Ruiz Meana, Marisol (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Vilahur, Gemma (Institut d'Investigació Biomèdica Sant Pau) ;
Vinten-Johansen, Jakob (Emory University, Atlanta, USA) ;
Yellon, Derek M. (The National Institute of Health Research University College London Hospitals Biomedical Research Centre, London, UK) ;
García-Dorado, David (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Universitat Autònoma de Barcelona
To commemorate the auspicious occasion of the 30th anniversary of IPC, leading pioneers in the field of cardioprotection gathered in Barcelona in May 2016 to review and discuss the history of IPC, its evolution to IPost and RIC, myocardial reperfusion injury as a therapeutic target, and future targets and strategies for cardioprotection. [...]
2016 - 10.1007/s00395-016-0588-8
Basic Research in Cardiology, Vol. 111 (october 2016)
|
|
guest ::
email alert
or subscribe to the 
RSS feed.
